Stem Point Capital LP Arcutis Biotherapeutics, Inc. Call Options Transaction History

Stem Point Capital LP

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$8.32 - $11.0 $39.5 Million - $52.3 Million	-4,750,000 Reduced 95.0%	250,000 $12.5 Million
Q2 2024 Aug 13, 2024	SELL	$7.24 - $12.53 $32.6 Million - $56.4 Million	-4,500,000 Reduced 90.0%	500,000 $350 Million
Q2 2024 Aug 13, 2024	BUY	$7.24 - $12.53 $36.2 Million - $62.7 Million	5,000,000 New	5,000,000 $350 Million

197

129M

738K

82K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $849M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Stem Point Capital LP, based on Form 13F filings with the SEC.

Stay updated on Stem Point Capital LP with notifications on news.